BNTX BioNTech SE Stock Quote

BNTX [NASD]

Index	-	P/E	76.69	EPS (ttm)	5.40	Insider Own	1.18%	Shs Outstand	243.12M	Perf Week	32.22%
Market Cap	95.29B	Forward P/E	13.82	EPS next Y	29.98	Insider Trans	0.00%	Shs Float	214.95M	Perf Month	94.12%
Income	1.42B	PEG	-	EPS next Q	9.01	Inst Own	14.90%	Short Float	0.95%	Perf Quarter	142.69%
Sales	2.98B	P/S	32.03	EPS this Y	107.10%	Inst Trans	9.31%	Short Ratio	0.62	Perf Half Y	251.16%
Book/sh	12.32	P/B	33.64	EPS next Y	-14.80%	ROA	53.50%	Target Price	195.09	Perf Year	398.30%
Cash/sh	4.61	P/C	89.88	EPS next 5Y	-	ROE	88.30%	52W Range	54.10 - 354.08	Perf YTD	408.39%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	4.90%	52W High	17.05%	Beta	-
Dividend %	-	Quick Ratio	2.60	Sales past 5Y	-	Gross Margin	88.60%	52W Low	666.06%	ATR	22.42
Employees	2200	Current Ratio	2.70	Sales Q/Q	7294.90%	Oper. Margin	65.50%	RSI (14)	91.03	Volatility	9.92% 7.50%
Optionable	Yes	Debt/Eq	0.23	EPS Q/Q	-	Profit Margin	47.80%	Rel Volume	4.18	Prev Close	351.81
Shortable	Yes	LT Debt/Eq	0.09	Earnings	Aug 09 BMO	Payout	0.00%	Avg Volume	3.27M	Price	414.44
Recom	2.50	SMA20	57.99%	SMA50	74.77%	SMA200	179.89%	Volume	13,636,281	Change	17.80%

Jul-19-21

Resumed

Wolfe Research

Outperform

$248

Jun-16-21

Downgrade

Redburn

Neutral → Sell

$146

May-18-21

Initiated

Goldman

Neutral

$173

May-11-21

Downgrade

Bryan Garnier

Buy → Neutral

$135 → $206

Dec-01-20

Downgrade

BofA Securities

Buy → Neutral

$123 → $126

Aug-03-20

Resumed

Berenberg

Buy

$98

Jul-21-20

Upgrade

BofA Securities

Neutral → Buy

$71 → $105

Jun-30-20

Downgrade

H.C. Wainwright

Buy → Neutral

May-19-20

Upgrade

H.C. Wainwright

Neutral → Buy

$48 → $69

Apr-28-20

Downgrade

BofA/Merrill

Buy → Neutral

$46 → $51

Mar-18-20

Downgrade

JP Morgan

Overweight → Neutral

$23 → $33

Mar-09-20

Initiated

H.C. Wainwright

Neutral

$30

Jan-24-20

Downgrade

SVB Leerink

Outperform → Mkt Perform

Jan-22-20

Downgrade

UBS

Buy → Neutral

$35

Nov-05-19

Initiated

Wolfe Research

Outperform

Nov-04-19

Initiated

UBS

Buy

$21

Nov-04-19

Initiated

SVB Leerink

Outperform

Nov-04-19

Initiated

JP Morgan

Overweight

$23

Nov-04-19

Initiated

Canaccord Genuity

Buy

$22

Nov-04-19

Initiated

BofA/Merrill

Buy

$21

Aug-04-21 01:18PM	Should the Lambda Variant Worry You? Not if Youre Vaccinated. Barrons.com +17.80%
12:28PM	Why BioNTech Stock Is Jumping Today Motley Fool
12:15PM	Dow Jones Loses 300 Points On Weak Jobs Data But Covid Stocks, Recent IPO Soar Investor's Business Daily
11:19AM	Delta variant is now in 135 countries, says WHO, as director-general calls for moratorium on boosters to allow poorer countries get first doses MarketWatch
10:30AM	Dow Jones Today, Stocks Slump As July Hiring Data Disappoints; FDA Timeline Lifts BioNTech; Paycom, DaVita Ace Breakouts Investor's Business Daily
09:23AM	BioNTech, Moderna Soar As WHO Wants Nations To Hold Off Boosters Investing.com
07:00AM	BioNTech Completes Acquisition of Kites Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland GlobeNewswire
03:08AM	Thai hospital tycoon who promised Pfizer vaccine says deal now unlikely Reuters
Aug-03-21 02:45PM	The Race Is On to Vaccinate School Kids This Year Barrons.com
02:25PM	Covid vaccine needs to be distributed exactly how the flu vaccines distributed: Henry Schein CEO Yahoo Finance Video
12:39PM	The Race Is On to Vaccinate School Kids This Year Barrons.com
12:26PM	Should You Consider Investing in the German Developer of the Pfizer Covid-19 Vaccine, BioNTech (BNTX)? Insider Monkey
10:09AM	BioNTech (BNTX) to Report Q2 Earnings: What's in the Cards? Zacks
05:52AM	This Could Be Pfizer's Next COVID Blockbuster -- and It Isn't a Vaccine Motley Fool
04:32AM	Sanofi to Buy Translate Bio for $3.2 Billion in mRNA Push Bloomberg
Aug-02-21 04:50PM	Pfizer, Moderna Reportedly Boost Covid Shot Prices And BioNTech Stock Pops Investor's Business Daily
03:55PM	Germany set to begin vaccinating teens 12 and over and offering COVID booster shots to older and at-risk people MarketWatch
01:55PM	Doctor on COVID-19: 'People who are vaccinated are still very susceptible to infection' Yahoo Finance Video
01:05PM	Latest Covid deaths are 'largely preventable' and 'inexcusable': Doctor Yahoo Finance Video
01:01PM	Is BioNTech SE (BNTX) A Smart Long-Term Buy? Insider Monkey
10:05AM	Dow Jones Today, Stocks Jump On Infrastructure Progress, China Bounce; BioNTech Leads Vaccine Rally Investor's Business Daily
08:42AM	Combining AstraZeneca and mRNA COVID-19 vaccines is effective -Danish study Reuters
07:00AM	BioNTech to Report Second Quarter Financial Results and Operational Update on August 9, 2021 GlobeNewswire
03:20AM	BioNTech, Moderna Gain On EU Deal For More Shots At Higher Prices Investing.com
Aug-01-21 09:34AM	How Novavax Could Shake Up the COVID Vaccine Market Motley Fool
07:51AM	Investing in These Stocks Now Could Make You a Millionaire Retiree Motley Fool
07:34AM	Worried About the Delta Variant? 5 Stocks to Insulate You From a COVID Market Crash Motley Fool
06:33AM	Better Biotech Stock: Moderna vs. BioNTech Motley Fool
Jul-31-21 01:25PM	Vaccine Mandates Could Be Good News for Vaccine Makers Barrons.com
08:02AM	Why Investors Should Like BioNTech's Latest Deal With Gilead Motley Fool
Jul-30-21 01:56PM	Doctor on Delta variant: All of us are extremely concerned Yahoo Finance Video +5.04%
01:34PM	WHO expert: Delta variant poses stark choice between behavior change or 'more lockdowns' Yahoo Finance
12:31PM	15 Most Valuable Biotech Companies in the World Insider Monkey
06:02AM	Why BioNTech Stock Jumped This Week Motley Fool
Jul-29-21 05:56PM	Why Moderna and BioNTech Slipped Today Motley Fool
02:27PM	Israel to offer third COVID-19 booster shot to citizens over 60 MarketWatch
02:06PM	We must move towards vaccine mandates to get ahead of Covid-19: Doctor Yahoo Finance Video
10:32AM	These 3 No-Brainer Tricks Will Help You Pick Millionaire-Maker Biotech Stocks Like BioNTech Motley Fool
06:39AM	Is Moderna a Buy? Motley Fool
06:00AM	Pfizer CEO on South Africa vaccine deal: 'They want to see production happening' Yahoo Finance
Jul-28-21 06:41PM	Why BioNTech Stock Shot Higher on Wednesday Motley Fool +10.37%
03:45PM	Pfizer authorizes $1 billion for oral COVID-19 treatment, CEO says Yahoo Finance
03:26PM	Pfizer: 'No issues' in testing for COVID-19 kid vaccine as Delta variant rises Yahoo Finance
02:21PM	Third Dose Of Pfizer-BioNTech's COVID-19 Vaccine Boosts Protection Against Delta Variant, New Data Reveals Benzinga
01:51PM	Covid-19 vaccine booster shots will become a reality: Doctor Yahoo Finance Video
09:56AM	Pfizer (PFE) Q2 Earnings Beat, View Up on COVID-19 Vaccine Zacks
09:37AM	Pfizer Covid Vaccine Sales Are Booming and Should Keep on Booming Barrons.com
08:19AM	Pfizer raises 2021 COVID-19 vaccine sales forecast to $33.5 billion Reuters
06:53AM	UPDATE 6-Pfizer says 2021 COVID-19 vaccine sales to top $33.5 bln, sees need for boosters Reuters
06:48AM	Pfizer says 2021 COVID-19 vaccine sales to top $33.5 billion, sees need for boosters Reuters
05:52AM	3 Big Hints That COVID Vaccine Booster Doses Are on the Way Motley Fool
02:52AM	Pfizer Blasts Earnings Forecast, Sees $33.5 Billion in COVID Vaccine Sales TheStreet.com
Jul-27-21 02:12PM	Theres a great opportunity that well have another variant: Doctor Yahoo Finance Video
10:00AM	Dow Jones Today, Stocks Slip As China Crackdown Weighs; FDA Boosts Moderna, BioNTech; Tesla Downshifts On Earnings Investor's Business Daily
09:27AM	AC Immune Secures Funding From BioNTech Investors, Buys Parkinson's Vaccine Candidate Benzinga
05:52AM	200 Million More Reasons to Buy Pfizer Stock Motley Fool
Jul-26-21 10:00PM	After Covid, BioNTech Has Its Sights Set on Malaria Motley Fool
09:44PM	BioNTech CEO Says Vaccine Is Growing Less Effective, but Still Prevents Severe Disease Barrons.com
07:40PM	Why BioNTech Rose as Much as 5% Today Motley Fool
05:45PM	BioNTech SE Sponsored ADR (BNTX) Outpaces Stock Market Gains: What You Should Know Zacks
03:59PM	Doctor on COVID-19 vaccination: Too little too late, better late than never, if anything it all counts Yahoo Finance Video
03:48PM	Were Hedge Funds Right About Piling Into BioNTech SE (BNTX)? Insider Monkey
12:00PM	Covid Boosters Are Coming This Year for People 50 and Older, Citi Analyst Predicts Barrons.com
11:53AM	CORRECTED-UPDATE 1-BioNTech aims to develop mRNA-based malaria vaccine Reuters
11:06AM	Covid Boosters Are Coming This Year for People 50 and Older, Citi Analyst Predicts Barrons.com
10:00AM	BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent GlobeNewswire
07:45AM	BioNTech Gains On Project Malaria Launch With Eye On Africa Vaccine Investing.com
Jul-25-21 06:31PM	25 Worst States For Covid Insider Monkey
05:52AM	3 Red-Hot Stocks That Are Still Dirt Cheap Motley Fool
Jul-23-21 01:53PM	Doctor on the Olympics regarding COVID-19: There are a lot of concerns Yahoo Finance Video
01:00PM	Dow Jones Rallies As Snap, Twitter Jump On Earnings Beats; Chinese Stocks Plunge On Crackdown Investor's Business Daily
10:58AM	Will Pfizer (PFE) Beat Expectations This Earnings Season? Zacks
10:32AM	Why This Companys Covid-19 Vaccine Is Just the Beginning InvestorPlace
10:09AM	Pfizer and BioNTech to Supply U.S. With 200 Million COVID Shots TheStreet.com
09:51AM	EU Drugs Regulator Recommends Moderna Shot for Teenagers Bloomberg
09:50AM	Fighting Infectious Diseases on the African Continent GlobeNewswire
06:54AM	Pfizer and BioNTech to supply U.S. govt with additional 200 million doses of COVID-19 vaccine MarketWatch
06:45AM	Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S. GlobeNewswire
06:45AM	Pfizer and BioNTech to Provide U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S. Business Wire
06:02AM	Why BioNTech, Moderna, and Novavax Stocks Soared This Week Motley Fool
05:52AM	3 Stocks to Buy Whether or Not a Market Crash Is Near Motley Fool
Jul-22-21 08:00PM	US buys 200m Pfizer jabs for children and possible boosters Financial Times +8.23%
02:36PM	We havent seen the high consequence variants yet: Doctor Yahoo Finance Video
11:00AM	Dow Jones Falls On Surprise Jump In Jobless Claims; Snap, Twitter Set To Report Earnings Investor's Business Daily
10:06AM	Pfizer (PFE) Inks Vaccine Deal, Faces FDA Delay on JAK Drugs Zacks
Jul-21-21 08:00PM	The race is on: CureVac seeks answers to vaccine disappointment Financial Times +5.89%
04:44PM	Dow Jones Regains Another 286 Points After Monday Sell-Off; Netflix Stock, Coca-Cola Move On Earnings Investor's Business Daily
03:17PM	Why BioNTech Stock Jumped Today Motley Fool
01:56PM	Dow Jones Rallies As Growth Stocks Shine; Netflix Gets Mauled; AMC Dips, Virgin Galactic Gains Investor's Business Daily
01:43PM	Its very premature to talk about booster vaccines: Doctor Yahoo Finance Video
12:27PM	Dow Jones Rallies As Netflix Slides On Earnings; Chipotle Surges On Earnings Beat Investor's Business Daily
10:45AM	UPDATE 1-South African firm to help make Pfizer/BioNTech COVID vaccine Reuters
09:54AM	The World Is Squandering Vaccines as New Wave Starts, WHO Chief Says Barrons.com
07:47AM	Pfizer, BioNTech partner with South African drug maker to make and distribute COVID-19 shot in Africa MarketWatch
07:15AM	Pfizer/BioNTech strike South Africa COVID-19 manufacturing deal with Biovac Reuters
07:15AM	Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa Business Wire
01:55AM	UPDATE 2-Taiwan bumps BioNTech vaccine order to 15 mln with Buddhist donation Reuters
Jul-20-21 11:46PM	Taiwan Buddhist group to buy 5 mln BioNTech vaccines Reuters
05:45PM	BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should Know Zacks
02:51PM	Likelihood of reaching herd immunity at this point is fairly low: Epidemiologist Yahoo Finance Video

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer.It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody, which is in Phase I/IIa clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience